Sonova beats expectations, lands USD 1.74bn revenue
Hearing aid manufacturer Sonova, which is headquartered in Switzerland, has seen the full benefits of the market recovery from Covid-19, and ends the first half of its financial year with revenue surpassing estimates. Nonetheless, the company has not upgraded its full-year guidance.
.jpg)
BY MARKETWIRE, TRANSLATED BY DANIEL PEDERSEN
The Swiss hearing aid manufacturer Sonova has announced its results from the skewed financial year 2021/2022, surpassing expectations in several key areas, it reports in its financial results from the period on Monday.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Sonova acquisition to drag out into 2022
For subscribers
Swiss media reports of defective Sonova cochlear implants
For subscribers
GN and Demant slightly increase Veteran Affairs foothold
For subscribers
